Published Nov 10, 2026, 12:40 PM ET · Updated 3 days ago · 1 source

MaxCyte falls after $151.8M deal to buy Akron Bio for cash and stock

Seeking Alpha
Seeking Alpha
·
Original Report

MaxCyte falls after $151.8M deal to buy Akron Bio for cash and stock